Are compounds acting at metabotropic glutamate receptors the answer to treating depression? (Q36654331)

15 August 2017

1 reference

title

Are compounds acting at metabotropic glutamate receptors the answer to treating depression? (English)

1 reference

Agnieszka Pałucha-Poniewiera

15 August 2017

author

series ordinal

1

object named as

Agnieszka Palucha

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Expert Opinion on Investigational Drugs

15 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 August 2017

volume

15

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

1545-1553

1 reference

Burden of disease--implications for future research

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Cost of disorders of the brain in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

The three faces of the antidepressants: a critical commentary on the clinical-economic context of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Modulation of glutamate receptors: molecular mechanisms and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Molecular diversity of glutamate receptors and implications for brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Pharmacology and functions of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Plasma and platelet excitatory amino acids in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Glucocorticoids, depression, and mood disorders: structural remodeling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Stress and hippocampal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Adrenal steroids suppress granule cell death in the developing dentate gyrus through an NMDA receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

The role of N-methyl-D-asparate receptors in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Depression: a case of neuronal life and death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

SM-20220, a potent Na /H exchange inhibitor, improves consciousness recovery and neurological outcome following transient cerebral ischaemia in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Repeated administration of antidepressants decreases field potentials in rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Antidepressants for the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

An open-label trial of riluzole in patients with treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Riluzole augmentation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

A role for AMPA receptors in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Group I metabotropic glutamate receptors: implications for brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

The olfactory bulbectomized rat as a model of depression: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Metabotropic glutamate autoreceptors of the mGlu(5) subtype positively modulate neuronal glutamate release in the rat forebrain in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Glutamate release inhibiting properties of the novel mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic-pituitary-adrenal axis activity: interaction with serotonergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Effects of dofetilide on cardiovascular tissues from normo- and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Tricyclic antidepressants activate the pituitary-adrenal axis in the rat. Tolerance to repeated drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

The effect of chronic administration of antidepressants on the circadian pattern of corticosterone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

Regulation of neurotransmitter release by metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.15.12.1545

10.1517/13543784.15.12.1545

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference